Price T Rowe Associates Inc. MD Grows Holdings in Paragon 28, Inc. (NYSE:FNA)

Price T Rowe Associates Inc. MD increased its position in Paragon 28, Inc. (NYSE:FNA) by 17.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,786 shares of the company’s stock after acquiring an additional 2,618 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Paragon 28 were worth $184,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Dimensional Fund Advisors LP boosted its stake in Paragon 28 by 8.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 100,405 shares of the company’s stock worth $1,037,000 after purchasing an additional 7,582 shares during the period. Marshall Wace LLP boosted its stake in Paragon 28 by 197.6% in the 4th quarter. Marshall Wace LLP now owns 91,713 shares of the company’s stock worth $947,000 after purchasing an additional 60,891 shares during the period. Jump Financial LLC bought a new position in shares of Paragon 28 during the 4th quarter valued at approximately $629,000. XTX Topco Ltd bought a new position in shares of Paragon 28 during the 4th quarter valued at approximately $170,000. Finally, Mariner LLC boosted its position in shares of Paragon 28 by 124.5% during the 4th quarter. Mariner LLC now owns 38,783 shares of the company’s stock valued at $401,000 after acquiring an additional 21,509 shares during the last quarter. 63.57% of the stock is currently owned by institutional investors.

Paragon 28 Stock Performance

NYSE:FNA opened at $13.11 on Friday. The stock’s fifty day moving average is $13.06 and its 200 day moving average is $11.66. Paragon 28, Inc. has a fifty-two week low of $4.65 and a fifty-two week high of $13.13. The firm has a market capitalization of $1.10 billion, a PE ratio of -17.71 and a beta of 1.47. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.60 and a current ratio of 3.50.

Paragon 28 (NYSE:FNA) last released its quarterly earnings results on Thursday, March 6th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.01). Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The company had revenue of $71.75 million for the quarter, compared to analysts’ expectations of $70.81 million. On average, sell-side analysts anticipate that Paragon 28, Inc. will post -0.64 earnings per share for the current year.

Insiders Place Their Bets

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 1,044,295 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $13.04, for a total value of $13,617,606.80. Following the sale, the insider now owns 7,810,588 shares in the company, valued at $101,850,067.52. This trade represents a 11.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold a total of 1,828,706 shares of company stock worth $23,810,399 over the last quarter. Company insiders own 15.32% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on FNA shares. Canaccord Genuity Group set a $13.00 target price on Paragon 28 in a research report on Wednesday, January 29th. Needham & Company LLC reiterated a “hold” rating and set a $13.00 target price on shares of Paragon 28 in a research report on Wednesday, January 29th. William Blair downgraded Paragon 28 from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Finally, Stephens restated an “equal weight” rating and set a $13.00 price target (down previously from $14.00) on shares of Paragon 28 in a report on Thursday, January 30th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $12.75.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.